Annual Long Term Debt
$29.82 M
+$10.38 M+53.44%
December 31, 2023
Summary
- As of February 7, 2025, TARS annual long term debt is $29.82 million, with the most recent change of +$10.38 million (+53.44%) on December 31, 2023.
- During the last 3 years, TARS annual long term debt has risen by +$29.27 million (+5331.51%).
- TARS annual long term debt is now at all-time high.
Performance
TARS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$71.71 M
+$130.00 K+0.18%
September 30, 2024
Summary
- As of February 7, 2025, TARS quarterly long term debt is $71.71 million, with the most recent change of +$130.00 thousand (+0.18%) on September 30, 2024.
- Over the past year, TARS quarterly long term debt has increased by +$41.89 million (+140.48%).
- TARS quarterly long term debt is now at all-time high.
Performance
TARS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
TARS Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +53.4% | +140.5% |
| 3 y3 years | +5331.5% | +140.5% |
| 5 y5 years | +100.0% | +140.5% |
TARS Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4997.3% | at high | >+9999.0% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | -100.0% | at high | >+9999.0% |
Tarsus Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $71.71 M(+0.2%) |
| Jun 2024 | - | $71.58 M(+139.1%) |
| Mar 2024 | - | $29.93 M(+0.4%) |
| Dec 2023 | $29.82 M(+53.4%) | $29.82 M(+0.4%) |
| Sep 2023 | - | $29.71 M(+20.7%) |
| Jun 2023 | - | $24.61 M(+0.4%) |
| Mar 2023 | - | $24.52 M(+26.1%) |
| Dec 2022 | $19.43 M | $19.43 M(-0.5%) |
| Sep 2022 | - | $19.52 M(-0.2%) |
| Jun 2022 | - | $19.56 M(-0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $19.61 M(+3251.3%) |
| Dec 2021 | $585.00 K(+6.6%) | $585.00 K(-22.5%) |
| Sep 2021 | - | $755.00 K(+86.4%) |
| Jun 2021 | - | $405.00 K(-11.2%) |
| Mar 2021 | - | $456.00 K(-16.9%) |
| Dec 2020 | $549.00 K(+449.0%) | $549.00 K(-12.2%) |
| Sep 2020 | - | $625.00 K(-16.0%) |
| Jun 2020 | - | $744.00 K(+644.0%) |
| Dec 2019 | $100.00 K(>+9900.0%) | $100.00 K |
| Dec 2018 | $0.00 | - |
FAQ
- What is Tarsus Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual long term debt year-on-year change?
- What is Tarsus Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly long term debt year-on-year change?
What is Tarsus Pharmaceuticals annual long term debt?
The current annual long term debt of TARS is $29.82 M
What is the all time high annual long term debt for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual long term debt is $29.82 M
What is Tarsus Pharmaceuticals annual long term debt year-on-year change?
Over the past year, TARS annual long term debt has changed by +$10.38 M (+53.44%)
What is Tarsus Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of TARS is $71.71 M
What is the all time high quarterly long term debt for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly long term debt is $71.71 M
What is Tarsus Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, TARS quarterly long term debt has changed by +$41.89 M (+140.48%)